Literature DB >> 26486142

Exosomes: Natural Carriers for siRNA Delivery.

Lalit Kumar, Shivani Verma, Bhuvaneshwar Vaidya1, Vivek Gupta.   

Abstract

Various cells of the human physiological system have the capability to release extracellular vesicles (EVs) involved in intercellular transport of proteins and nucleic acids. Exosomes are a subtype of extracellular vesicles having their origin through endocytic pathway. While being involved in intercellular transport of macromolecules, exosomes, due to their presence in several body fluids, can also be utilized as a system to commute RNA molecules and proteins in the body. Recent advances in gene therapy have provided a new outlook in disease therapeutics by modulation of gene expression using oligonucleotide based approach and exosomes have been reported a potential carrier for nucleic acid based therapeutic moieties. In recent years, small interfering RNA (siRNA) has emerged as promising therapeutic alternative for diseases with gene-based pathophysiology, however poor bioavailability limits its therapeutic potential. For effective delivery and enhancement of bioavailability of siRNA, several carriers including dendrimers, liposomes, siRNA conjugates, and siRNA aptamer chimeras, to name a few, have been explored. Exosomes can be considered a promising carrier for effective delivery of siRNA due to their existence in body's endogenous system and high tolerance. The present review focuses on delivering knowledge about exosomes, siRNA, and capability of exosomes to act as natural carriers for siRNA delivery.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26486142     DOI: 10.2174/138161282131151013190112

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  11 in total

1.  Exosomes from iPSCs Delivering siRNA Attenuate Intracellular Adhesion Molecule-1 Expression and Neutrophils Adhesion in Pulmonary Microvascular Endothelial Cells.

Authors:  Zhihai Ju; Jinhui Ma; Chen Wang; Jie Yu; Yeru Qiao; Feilong Hei
Journal:  Inflammation       Date:  2017-04       Impact factor: 4.092

2.  Salivary exosomes as a new therapy to ameliorate diabetes mellitus and combat xerostomia and submandibular salivary glands dysfunction in diabetic rats.

Authors:  Zeinab A Salem; Amany Hany Mohamed Kamel; Nermeen AbuBakr
Journal:  J Mol Histol       Date:  2021-01-03       Impact factor: 2.611

3.  Dark-Side of Exosomes.

Authors:  Atilla Engin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.

Authors:  Stephen J Haggarty; M Catarina Silva; Alan Cross; Nicholas J Brandon; Roy H Perlis
Journal:  Mol Cell Neurosci       Date:  2016-01-28       Impact factor: 4.314

Review 5.  Diagnostic and therapeutic potential of microRNAs in neuropsychiatric disorders: Past, present, and future.

Authors:  Begum Alural; Sermin Genc; Stephen J Haggarty
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2016-04-09       Impact factor: 5.067

Review 6.  Dairy consumption and hepatocellular carcinoma risk.

Authors:  Bodo C Melnik
Journal:  Ann Transl Med       Date:  2021-04

Review 7.  Repurposing Antiviral Protease Inhibitors Using Extracellular Vesicles for Potential Therapy of COVID-19.

Authors:  Santosh Kumar; Kaining Zhi; Ahona Mukherji; Kelli Gerth
Journal:  Viruses       Date:  2020-04-26       Impact factor: 5.048

Review 8.  Clinical Potential of Extracellular Vesicles in Type 2 Diabetes.

Authors:  Jie Liu; Xin Sun; Fu-Liang Zhang; Hang Jin; Xiu-Li Yan; Shuo Huang; Zhen-Ni Guo; Yi Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-21       Impact factor: 5.555

9.  Natural killer cell-derived exosomal miR-1249-3p attenuates insulin resistance and inflammation in mouse models of type 2 diabetes.

Authors:  Ying Wang; Mengwei Li; Lin Chen; Huan Bian; Xiangying Chen; Huilin Zheng; Peiwei Yang; Quan Chen; Hanmei Xu
Journal:  Signal Transduct Target Ther       Date:  2021-11-30

Review 10.  A Defective Viral Particle Approach to COVID-19.

Authors:  Maria Kalamvoki; Vic Norris
Journal:  Cells       Date:  2022-01-17       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.